Buy alert at Ligand Pharmaceuticals: After +60% revenue growth, strategic investments are now being made in the pharma market!
Reading Time: 3 minutes
Ligand Pharmaceuticals (LGND) focuses on financially and technologically supporting partner companies in the research and development of life-saving therapeutics. In an era where drug development is becoming increasingly complex and costly, Ligand offers a crucial technology with its proven Captisol platform to optimize the solubility and stability of active ingredients. The company serves a wide spectrum: instead of bearing the immense risk and costs of its own pipeline, Ligand builds a broadly diversified portfolio of lucrative license and milestone...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.

